macular degeneration
Let an agent explain macular degeneration and its forms in general terms from clinical guidelines, relay risk factors, diagnosis and treatment approaches, distinguish age-related from inherited forms, and route personal eye questions to eye care professionals.
Research draft, second pass
A second pass drafted this model: the structure a model of this thing needs, and what is known about it in the world. The line under this one says how the second half was obtained - researched against sources, or recalled without web access, in which case nothing here was read anywhere and every claim is a lead to verify. Unreviewed either way.
written by Claude from model knowledge without web access - no source was read, every claim is a lead to verify
Researched by: Claude
Purpose and description
Let an agent explain macular degeneration and its forms in general terms from clinical guidelines, relay risk factors, diagnosis and treatment approaches, distinguish age-related from inherited forms, and route personal eye questions to eye care professionals.
A group of eye conditions in which the macula, the central part of the retina responsible for sharp vision, deteriorates, chiefly age-related macular degeneration in dry form progressing to geographic atrophy and wet form with abnormal blood vessels, and inherited macular dystrophies such as Best vitelliform dystrophy and other bestrophinopathies, pattern dystrophies and occult macular dystrophy; macular degeneration is a leading cause of vision loss in older people and is managed with monitoring, injections for wet forms, supplements and low vision support.
What it is for: Not applicable; a group of eye conditions.
It can be explain forms and causes; relay diagnosis and treatment approaches; distinguish age-related from inherited forms; route personal questions.
Distinguishing features
Central vision loss
Age-related and inherited forms
Anti-VEGF treatment for wet AMD
Preserved peripheral vision
What it looks like
Not a visible object; retinal changes seen on examination and imaging.
Physical character
people with AMD worldwide: about 200 million people - estimates
share of AMD that is wet: about 10-15 percent
How it is recognised
Deterioration of the central retina
Dry and wet age-related forms, geographic atrophy, inherited dystrophies
Glaucoma affects the optic nerve; cataract affects the lens; diabetic retinopathy is vascular
Related models
is a kind of - in registry terms
is a kind of - in registry terms
is a kind of - in registry terms, as a cause of vision loss
is treated with - in wet forms
In practice
Families and kinds
dry age-related macular degeneration
geographic atrophy
wet or neovascular age-related macular degeneration
Best disease and other bestrophinopathies
vitelliform and pattern macular dystrophies
occult macular dystrophy
myopic macular degeneration
Identifiers
ICD-11 9B75 degeneration of macula and posterior pole
MeSH D008268 macular degeneration
Standards and regulation
Ophthalmology guidelines on AMD management
Approval of anti-VEGF and complement inhibitor therapies
Low vision and disability support rules
Failure modes and hazards
Delayed treatment of wet AMD
Agents giving personal medical advice
Confusing forms
Unproven supplements
Also called
Where this came from
wikidata · CC0 1.0
Also registered as vr.tr.macular-degeneration
Drafted structure
Bundle to layer to finding to question, as the second pass will find it: 4 bundles · 8 layers · 8 findings · 16 questions.
Help Getting help first.
Safety.
Urgent
Urgent signs.
Urgent
Urgent.
- What sudden vision changes need urgent eye care? action
- Is the user describing sudden distortion or loss of vision, which needs prompt eye care? boundary
Care
Eye care.
Care
Care.
- How is macular degeneration diagnosed and monitored by eye care professionals, in general terms? provenance
- Is the user asking about their own eyes, which needs an eye care professional? boundary
Understand The conditions.
Clinical.
Forms
Forms and causes.
Forms
Forms.
- What forms of macular degeneration exist, and what causes them? definition
- Is the question about age-related or inherited macular degeneration? boundary
Risk
Risk factors.
Risk
Risk.
- What risk factors, including age, smoking and genetics, does research identify? provenance
- Which entry fits the specific form? action
Treat Treatment and living.
Clinical.
Treatment
Treatment.
Treatment
Treatment.
- What treatments exist for wet and dry forms, per guidelines, in general terms? provenance
- Which references are standard? provenance
Living
Living with vision loss.
Living
Living.
- What low vision aids and support services exist? provenance
- Which entry fits low vision rehabilitation? action
Context Research and epidemiology.
Context.
Research
Research.
Research
Research.
- What research is ongoing on gene therapy, complement inhibition and cell therapy, with findings attributed? provenance
- Which sources are cited? provenance
Epidemiology
Epidemiology.
Epidemiology
Epidemiology.
- How common is macular degeneration, and how is prevalence changing, with sources? measurement
- Which entry fits global vision loss? action
What the second pass must settle
- Should age-related macular degeneration be a separate primary entry?
- How should guidelines be linked?
- The registry entry has merged aliases naming inherited dystrophies and classifications; should they be split off?